WBA:NGS-Walgreens Boots Alliance Inc.

EQUITY | Pharmaceutical Retailers | Nasdaq Global Select

Last Closing

USD 55.89

Change

+0.15 (+0.27)%

Market Cap

USD 90.91B

Volume

3.58M

Analyst Target

USD 58.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Walgreens Boots Alliance Inc operates drug-stores chain in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drug-stores, as well as mail, and by telephone and online.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
HITI High Tide Inc

-0.01 (-0.47%)

USD 0.18B
PETS PetMed Express Inc

+0.10 (+2.47%)

USD 0.10B
BIMI Bimi International Medical Inc

+0.20 (+17.86%)

USD 0.02B
MEDS Trxade Group Inc

-0.16 (-2.40%)

USD 7.75M
CJJD China Jo-Jo Drugstores Inc

-0.07 (-2.33%)

USD 5.39M
LFLY Leafly Holdings Inc

-0.06 (-2.74%)

USD 4.99M
MDVL Medavail Holdings Inc

N/A

USD 2.91M
LFLYW Leafly Holdings Inc

N/A

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing WBA

DOGG 6.21 % 0.00 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FMK 0.00 % 0.70 %

N/A

N/A
IBDK 0.00 % 0.10 %

N/A

N/A
PEY Invesco High Yield Equity.. 0.00 % 0.53 %

+0.14 (+0%)

USD 1.20B
IVFVC 0.00 % 0.00 %

N/A

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.21% 100% F 16% F
Dividend Return 1.29% 50% F 49% F
Total Return -16.92% 100% F 17% F
Trailing 12 Months  
Capital Gain -14.24% 100% F 45% F
Dividend Return 2.70% 50% F 65% D
Total Return -11.54% 100% F 46% F
Trailing 5 Years  
Capital Gain -21.93% 67% D+ 35% F
Dividend Return 9.74% 50% F 41% F
Total Return -12.19% 67% D+ 35% F
Average Annual (5 Year Horizon)  
Capital Gain -1.31% 42% F 36% F
Dividend Return 0.60% 47% F 36% F
Total Return 1.90% 58% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 16.55% 89% A- 71% C-
Risk Adjusted Return 3.60% 47% F 36% F
Market Capitalization 90.91B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Pharmaceutical Retailers) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 10.94 67% 81%
Price/Book Ratio 2.09 50% 47%
Price / Cash Flow Ratio 0.00 75% 61%
Price/Free Cash Flow Ratio 0.00 75% 57%
Management Effectiveness  
Return on Equity 17.99% 75% 87%
Return on Invested Capital N/A N/A N/A
Return on Assets 4.95% 75% 80%
Debt to Equity Ratio 47.80% 100% 43%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.